TIMOTHY FLEMING: Open Payments
NPI 1043315062 · IRONDALE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,726 in 56 payments from 15 companies in 2025. Trend: 2023 $270 · 2024 $147 · 2025 $1,726
Food & beverage: $1,726
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 15 | $502 |
| Novo Nordisk Inc | 12 | $461 |
| Dexcom, Inc. | 4 | $179 |
| Otsuka America Pharmaceutical, Inc. | 3 | $163 |
| Lilly USA, LLC | 5 | $93 |
| ABBVIE INC. | 3 | $67 |
| Exact Sciences Corporation | 3 | $51 |
| Antares Pharma, Inc. | 2 | $42 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $35 |
| Amgen Inc. | 2 | $34 |
Products named: Ozempic, AIRSUPRA, REXULTI, DEXCOM G7 GSS (161), BREZTRI, Cologuard Collection Kit, VRAYLAR, Dexcom G6 Transmitter.
Industry payments across AL — which companies pay providers there.
